NCOA3 and complete blood cell count: We also evaluate AIB1-expression in relation to prognosis and tamoxifen response after diagnosis of CBC, both in the treatment naïve (CBC without prior tamoxifen) and presumably resistant setting (CBC despite prior tamoxifen).